Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Madrigal Pharmaceuticals, Inc. (MDGL) had Return on Equity of -47.83% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$958.40M |
|
$-288.28M |
|
$56.15M |
|
$902.25M |
|
$1.26B |
|
$-300.10M |
|
$11.81M |
|
$-288.28M |
|
$-288.28M |
|
$-288.28M |
|
$-288.28M |
|
$-288.28M |
|
$-288.28M |
|
$-300.10M |
|
$-293.78M |
|
22.43M |
|
22.43M |
|
$-12.85 |
|
$-12.85 |
|
| Balance Sheet Financials | |
$1.25B |
|
$1.50M |
|
$13.82M |
|
$1.26B |
|
$310.29M |
|
$339.88M |
|
$346.61M |
|
$656.90M |
|
$602.69M |
|
$595.31M |
|
$602.69M |
|
22.84M |
|
| Cash Flow Statement Financials | |
$-189.55M |
|
$32.32M |
|
$255.98M |
|
$105.02M |
|
$203.78M |
|
$98.76M |
|
$98.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.01 |
|
-- |
|
-- |
|
0.36 |
|
0.56 |
|
94.14% |
|
-31.31% |
|
-31.31% |
|
-30.65% |
|
-30.08% |
|
-30.08% |
|
$-190.02M |
|
-- |
|
-- |
|
-- |
|
0.76 |
|
0.75 |
|
7.13 |
|
51.21 |
|
|
Return on Equity |
-47.83% |
-48.43% |
|
-22.89% |
|
-30.58% |
|
$26.39 |
|
$-8.47 |
|
$-8.45 |
|